Treatment of the patient with primary familial heterozygous hypercholesterolemia

B R Avery1

  • 1Lipid Institute, Sequoia Hospital, Redwood City, California, USA.

Insights

Familial heterozygous hypercholesterolemia (FH) is a genetic lipid disorder causing high cholesterol. This case study highlights how nursing care improved patient adherence to a 4-year treatment plan for FH and coronary heart disease.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Background:

  • Familial heterozygous hypercholesterolemia (FH) is an inherited condition characterized by elevated total cholesterol and LDL cholesterol.
  • Approximately 5% of individuals with coronary heart disease (CHD) have FH, indicating a significant overlap between these conditions.
  • Standard treatment for FH includes lifestyle modifications (diet, weight management, exercise) and pharmacotherapy.

Observation:

  • A case study details a patient's 4-year treatment journey following a CHD diagnosis, complicated by FH.
  • The patient's adherence to the prescribed treatment regimen was a critical factor in managing their condition.
  • Nursing interventions played a pivotal role in supporting the patient's compliance throughout the treatment period.

Findings:

  • Effective management of FH in patients with CHD requires a comprehensive approach.
  • Sustained patient adherence to treatment is crucial for mitigating cardiovascular risk.
  • Nursing care is instrumental in facilitating patient adherence and improving outcomes in complex lipid disorders.

Implications:

  • This case underscores the importance of integrating genetic lipid disorder management into cardiovascular care pathways.
  • Enhanced patient education and support, particularly from nursing staff, can significantly improve treatment adherence in FH.
  • Further research into the long-term impact of nursing interventions on FH management and cardiovascular outcomes is warranted.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...